Stocks · News reference

Shoulder Innovations Enters Into A Settlement Agreement With Catalyst Orthoscience To Resolve All Outstanding Patent Litigation Between The Two Companies

Sep 8, 2026, 8:15 PMBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaSep 9, 2026, 8:28 PMBenzinga Newsdesk
Shoulder Innovations Enters Into Exclusive Collaboration With ALM Ortho For Bespoke Shoulder Implant; Financial Terms Remain Confidential
Shoulder Innovations, Inc. ("Shoulder Innovations", or "the company") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today
SI
BenzingaAug 10, 2026, 8:21 PMBenzinga Newsdesk
UBS Maintains Buy on Shoulder Innovations, Raises Price Target to $28
UBS analyst Patrick Wood maintains Shoulder Innovations (NYSE:SI) with a Buy and raises the price target from $27 to $28.
SI
SEC EDGARAug 10, 2026, 11:09 AMSEC EDGAR
8-K filing — SHOULDER INNOVATIONS, INC. (SI)
Filed: 2026-08-10 AccNo: 0001699350-26-000054 Size: 158 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
SI